English  |  正體中文  |  简体中文  |  2826208  
???header.visitor??? :  31907968    ???header.onlineuser??? :  1353
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"shih j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 336-360 of 1137  (46 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-04-29T05:09:17Z Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:15Z Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer Wu J.-Y.; Shih J.-Y.; Yang C.-H.; KUAN-YU CHEN; Ho C.-C.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:15Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; KUAN-YU CHEN; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:14Z Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer Lee J.-H.; Yu C.-J.; KUAN-YU CHEN; Shih J.-Y.; Lin Y.-L.; Yang C.-H.
臺大學術典藏 2021-04-29T05:09:14Z Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors KUAN-YU CHEN; Chen J.-H.; Shih J.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:12Z The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma Kuo Y.-W.; Jerng J.-S.; Shih J.-Y.; KUAN-YU CHEN; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:12Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y.; Shih J.-Y.; KUAN-YU CHEN; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:11Z Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; KUAN-YU CHEN; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:10Z Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors Hsu C.-L.; KUAN-YU CHEN; Shih J.-Y.; Ho C.-C.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:07Z Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; KUAN-YU CHEN; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2021-04-29T05:09:07Z Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer Liao W.-Y.; Chen J.-H.; Wu M.; Shih J.-Y.; KUAN-YU CHEN; Ho C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-04-29T05:09:06Z Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer Lee J.-H.; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; KUAN-YU CHEN; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H.
臺大學術典藏 2021-04-29T05:09:04Z Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis Hsu C.-L.; Chen J.-H.; KUAN-YU CHEN; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:03Z Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan Hsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Chang G.-C.
臺大學術典藏 2021-04-29T05:09:03Z Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer Chen C.-Y.; Lin J.-W.; Huang J.-W.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:02Z EGFR mutation and lobar location of lung adenocarcinoma Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C.
臺大學術典藏 2021-04-29T05:08:57Z Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:56Z Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer Chen C.-Y.; Chen Y.-Y.; Hsieh M.-S.; Ho C.-C.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:55Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib Yao Z.-H.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:55Z Coexistence of the BRAF Mutation and EGFR Exon 20?Insertion in a Patient with Lung Adenocarcinoma Chang L.-C.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.; Hsieh M.-S.
臺大學術典藏 2021-04-29T05:08:54Z Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression Chen C.-Y.; Chen Y.-Y.; Chen J.J.W.; KUAN-YU CHEN; Ho C.-C.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:08:54Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; KUAN-YU CHEN; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:53Z Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go? Lim C.-K.; Wei Y.-F.; Tsai M.-S.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:53Z Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum Liao W.-Y.; Ho C.-C.; Tsai T.-H.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:53Z Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; KUAN-YU CHEN; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.

Showing items 336-360 of 1137  (46 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page